Back to Search
Start Over
Biphosphonate-associated osteonecrosis can be controlled by nonsurgical management
- Publication Year :
- 2007
-
Abstract
- Sixteen patients with jaw biphosphonate-osteonecrosis and with exposed bone areas were subdivided into 2 treatment groups. The first group (7 patients) underwent superficial or radical surgical therapy, while the second (9 patients) underwent antibiotic treatment. A slight reduction of the necrotic areas was observed in 5 of 7 patients in the first group, whereas no change was observed in the remaining 2 patients at 22- and 24-month follow-up. A slight reduction of the necrotic areas was observed in 7 of 9 patients in the second group, whereas no change was observed in the remaining 2 patients at 5- and 24-month follow-up. The statistical analysis showed that the treatment regimen did not significantly influence the dimensional change in the exposed bone. The preliminary results seem to suggest that biphosphonate-associated osteonecrosis can be well controlled by a nonsurgical protocol consisting in long-term administration of antibiotics.
- Subjects :
- Male
medicine.medical_specialty
medicine.drug_class
OSTEONECROSIS
medicine.medical_treatment
Antibiotics
Pamidronate
Amoxicillin-Potassium Clavulanate Combination
Zoledronic Acid
Surgical therapy
Biphosphonate
Metronidazole
medicine
Humans
Statistical analysis
Prospective Studies
Prospective cohort study
General Dentistry
Reduction (orthopedic surgery)
Aged
Analysis of Variance
Bone Density Conservation Agents
Diphosphonates
business.industry
Treatment regimen
Imidazoles
Middle Aged
Anti-Bacterial Agents
Surgery
Zoledronic acid
Otorhinolaryngology
BIPHOSPHONATE
Linear Models
Female
Oral Surgery
business
Jaw Diseases
medicine.drug
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....2a8988dbb62ef65ad8df52d376d5f168